Evidence map›Paper›PMID 35225984›Full record

ArticleJournal of functional biomaterials2022

SpAD Biofunctionalized Cellulose Acetate Scaffolds Inhibit

Stefanos Pendas, Antonis Asiminas, Alexandros Katranidis, Costas Tsioptsias, Maria Pitou, Georgios Papadopoulos, Theodora Choli-Papadopoulou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Stefanos PendasLaboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Antonis AsiminasDivision of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, Nørre Alle 14, 24.3.9, 2200 Copenhagen N, Denmark.
Alexandros KatranidisInstitute of Biological Information Processing IBI-6, Forschungszentrum Jülich (FZJ), 52425 Jülich, Germany.ORCID 0000-0002-1785-1659
Costas TsioptsiasDepartment of Chemical Εngineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Maria PitouLaboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-1929-227X
Georgios PapadopoulosDepartment of Biochemistry and Biotechnology, University of Thessaly, Biopolis, 41500 Larissa, Greece.
Theodora Choli-PapadopoulouLaboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRForschungszentrum Jülich · DEUniversity of Copenhagen · DKUniversity of Thessaly · GR

Funding

European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH - CREATE - INNOVATE T1EDK-04567
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterial propertiescellulose acetate scaffoldsS. aureus protein Avon Willebrand factor A1

Identifiers

PMID35225984
PMCPMC8883972
OpenAlexW4213290396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.